Gavison Plus Suspension

Acid regurgitation, heart burn, indigestion and hyperacidity. It can also be used to treat the symptoms of gastroesophageal reflux during concomitant treatment with or following withdrawal of acid suppresing therapy

Adults and children over 12 years: 10-20 ml after meals and at bedtime. Up to 4 times per day. Children under 12 years: Should be given only on medical advice

Pregnancy: Clinical studies in more than 281 pregnant women did not demonstrate any significant advers effect on the course of pregnancy or on the health of the foetus/newborn child. This product may be used during pregnancy, if clinicaly needed Breast feeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breast-feeding

A time-interval of 2 hours should be considered between this drug intake and the administration of other medicinal products, especially anti-histamin, tetracyclines, digoxine, fluoroquinolone, iron salt, ketoconazole, neuroleptics, thyroxine, thyroid hormones, penicillamine, beta-blockers (atenolol, metoprolol, propanolol), glucocorticoid, chloroquine and biphosphonates(diphosphonates) and estramustine.

Very rare (frequency: <1/10,000): Anaphylactic reaction, anaphylactoid reaction, urticaria, bronchospasm

Gavison Plus Suspension manufactured by Mediearth Limited. Its generic name is Amritavalli.